•  
  •  
 

Abstract

Hydroxytyrosol (HT), a simple phenol abundant in olive oil, is recognized for its antioxidant, anti-inflammatory, and anti-cancer properties. Evidence suggests that HT plays a notable role in triggering immune responses, specifically through mechanisms that induce apoptosis. Proteinase Inhibitor 9 (PI-9) affects the ability of immune cells to kill cancer cells, and as a result, it is associated with poor prognosis in carcinomas. PI-9 targets Granzyme B (GrB) released by cytotoxic cells and protects cells from apoptosis. In this project, we studied the antiproliferative effects of HT in Estrogen Receptor-Positive (ER+) and Estrogen Receptor-Negative (ER-) mammary carcinoma cells. We also examined whether HT regulates PI-9 and GrB in these cells. Our results demonstrated the suppression of cell growth in the three breast cancer cell lines. Findings also indicate that HT exposure suppressed PI-9 protein levels in ER+ MCF-7 and T47D cell lines, yet triggered GrB upregulation exclusively within the T47D cells. In ER-MDA-MB-453 cells, we observed that HT suppressed the protein expression of PI-9 and did not alter the expression of GrB. These results show that HT modulates PI-9 in all the three mammary carcinoma cells, however the regulatory effects of GrB by HT is not universal among breast cancer models. Subsequent studies will explore the potential of fine-tuning PI-9 and GrB expression as a strategy to augment immune-targeted cytotoxicity in diverse breast cancer phenotypes.

Included in

Life Sciences Commons

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.